These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 8150411

  • 1. Potential and limitations of Tc-99m sestamibi scintigraphy for the diagnosis of myocardial viability.
    Cornel JH, Arnese M, Forster T, Postma-Tjoa J, Reijs AE, Fioretti PM.
    Herz; 1994 Feb; 19(1):19-27. PubMed ID: 8150411
    [Abstract] [Full Text] [Related]

  • 2. [Thallium scintigraphy for determining myocardial vitality. Evaluation of the "stunned and hibernating myocardium"].
    Nienaber CA, Carnarius H.
    Herz; 1994 Feb; 19(1):7-18. PubMed ID: 8150416
    [Abstract] [Full Text] [Related]

  • 3. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC, Mody FV, Hawkins RA, Nienaber CA, Phelps ME, Schelbert HR.
    Herz; 1994 Feb; 19(1):28-41. PubMed ID: 8150412
    [Abstract] [Full Text] [Related]

  • 4. Combined analysis of resting regional wall thickening and stress perfusion with electrocardiographic-gated technetium 99m-labeled sestamibi single-photon emission computed tomography: prediction of stress defect reversibility.
    Snapper HJ, Shea NL, Konstam MA, Oates E, Udelson JE.
    J Nucl Cardiol; 1997 Feb; 4(1 Pt 1):3-10. PubMed ID: 9138837
    [Abstract] [Full Text] [Related]

  • 5. Prediction of functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction combining the evaluation of myocardial perfusion and of contractile reserve using nitrate-enhanced technetium-99m sestamibi gated single-photon emission computed tomography and dobutamine stress.
    Leoncini M, Marcucci G, Sciagrà R, Frascarelli F, Simonetti I, Bini L, Maioli M, Mennuti A, Dabizzi RP.
    Am J Cardiol; 2001 Jun 15; 87(12):1346-50. PubMed ID: 11397351
    [Abstract] [Full Text] [Related]

  • 6. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G, Schneider-Eicke J, Schwaiger M.
    Herz; 1994 Feb 15; 19(1):42-50. PubMed ID: 8150413
    [Abstract] [Full Text] [Related]

  • 7. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
    Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, Marin-Neto JA, Katsiyiannis PT, Bonow RO.
    Circulation; 1994 Feb 15; 89(2):578-87. PubMed ID: 8313546
    [Abstract] [Full Text] [Related]

  • 8. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J, Altehoefer C, Büchin P, Sheehan FH, Schwarz ER, Koch KC, Schulz G, Uebis R, Schöndube F, Messmer BJ, Büll U, Hanrath P.
    Z Kardiol; 1996 Nov 15; 85(11):868-81. PubMed ID: 9064949
    [Abstract] [Full Text] [Related]

  • 9. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability.
    Duncan BH, Ahlberg AW, Levine MG, McGill CC, Mann A, White MP, Mather JF, Waters DD, Heller GV.
    Am J Cardiol; 2000 Mar 15; 85(6):680-4. PubMed ID: 12000040
    [Abstract] [Full Text] [Related]

  • 10. Assessment of regional and global left ventricular function by reinjection T1-201 and rest Tc-99m sestamibi ECG-gated SPECT: comparison with three-dimensional magnetic resonance imaging.
    Tadamura E, Kudoh T, Motooka M, Inubushi M, Shirakawa S, Hattori N, Okada T, Matsuda T, Koshiji T, Nishimura K, Matsuda K, Konishi J.
    J Am Coll Cardiol; 1999 Mar 15; 33(4):991-7. PubMed ID: 10091826
    [Abstract] [Full Text] [Related]

  • 11. Selective intracoronary injection of sestamibi to detect myocardial viability: Prediction of perfusion and contractile recovery after percutaneous transluminal coronary angioplasty.
    Trani C, Giordano A, Lombardo A, Lupi A, Reale F, Patrizi R, Patrizi G, Mazzari MA, Schiavoni G, Maseri A.
    J Nucl Cardiol; 2003 Mar 15; 10(5):473-81. PubMed ID: 14569240
    [Abstract] [Full Text] [Related]

  • 12. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery.
    Sciagrà R, Bisi G, Santoro GM, Zerauschek F, Sestini S, Pedenovi P, Pappagallo R, Fazzini PF.
    J Am Coll Cardiol; 1997 Aug 15; 30(2):384-91. PubMed ID: 9247509
    [Abstract] [Full Text] [Related]

  • 13. Nitrate versus rest myocardial scintigraphy with technetium 99m-sestamibi: relationship of tracer uptake to regional left ventricular function and its significance in the detection of viable hibernating myocardium.
    Sciagrà R, Bisi G, Santoro GM, Rossi V, Fazzini PF.
    Am J Card Imaging; 1995 Jul 15; 9(3):157-66. PubMed ID: 7549355
    [Abstract] [Full Text] [Related]

  • 14. [Simultaneous assessment of perfusion and myocardial viability with 2 isotope studies (thallium at rest and sestamibi in exercise). Initial experience in Mexico and Latin America].
    Alexánderson E, Varguez V, Bialostozky D, Arroyo A, Alexánderson G, Victoria D.
    Arch Inst Cardiol Mex; 1997 Jul 15; 67(2):106-13. PubMed ID: 9412421
    [Abstract] [Full Text] [Related]

  • 15. Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction: importance of infarct location adjusted thresholds.
    Schneider CA, Voth E, Gawlich S, Baer FM, Horst M, Schicha H, Erdmann E, Sechtem U.
    J Am Coll Cardiol; 1998 Sep 15; 32(3):648-54. PubMed ID: 9741506
    [Abstract] [Full Text] [Related]

  • 16. Myocardial contractile reserve and perfusion defect severity with rest and stress dobutamine (99m)Tc-sestamibi SPECT in canine stunning and subendocardial infarction.
    Chin BB, Esposito G, Kraitchman DL.
    J Nucl Med; 2002 Apr 15; 43(4):540-50. PubMed ID: 11937600
    [Abstract] [Full Text] [Related]

  • 17. [Estimation of myocardial viability and clinical significance of reverse redistribution in resting technetium-99m sestamibi myocardial single photon emission computed tomography in patients with acute myocardial infarction].
    Itagane H, Otsuka M, Yamagishi H, Suto Y, Kajiwara K, Naruko T, Tojo O, Okumachi F, Haze K.
    J Cardiol; 1997 Oct 15; 30(4):179-88. PubMed ID: 9365855
    [Abstract] [Full Text] [Related]

  • 18. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS, Kiat H, Maddahi J.
    Circulation; 1991 Sep 15; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [Abstract] [Full Text] [Related]

  • 19. Technetium-99m sestamibi tomographic evaluation of residual ischemia after anterior myocardial infarction.
    Marcassa C, Galli M, Temporelli PL, Campini R, Orrego PS, Zoccarato O, Giordano A, Giannuzzi P.
    J Am Coll Cardiol; 1995 Mar 01; 25(3):590-6. PubMed ID: 7860901
    [Abstract] [Full Text] [Related]

  • 20. Effect of left ventricular function on the assessment of myocardial viability by technectium-99m sestamibi and correlation with positron emission tomography in patients with healed myocardial infarcts or stable angina pectoris, or both.
    Arrighi JA, Ng CK, Dey HM, Wackers FJ, Soufer R.
    Am J Cardiol; 1997 Oct 15; 80(8):1007-13. PubMed ID: 9352969
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.